Publications

Do changes in drug coverage policy point to an increased role for cost-effectiveness analysis in the USA?

Published on May 24, 2014 Citation: Chambers JD. Do changes in drug coverage policy point to an increased role for cost-effectiveness analysis in the USA? Pharmacoeconomics. 2014 Aug;32(8):729-33. Journal: PharmacoEconomics Read Publication

Abdominal aortic aneurysm screening: how many life years lost from underuse of the Medicare screening benefit?

Published on April 9, 2014 Citation: Olchanski N, Winn A, Cohen JT, Neumann PJ. Abdominal aortic aneurysm screening: how many life years lost from underuse of the Medicare screening benefit? J Gen Intern Med. 2014 Aug;29(8):1155-61. Journal: Journal of General Internal Medicine Read Publication

Unintended benefits: the potential economic impact of addressing risk factors to prevent Alzheimer's disease

Published on April 1, 2014 Citation: Lin PJ, Yang Z, Fillit HM, Cohen JT, Neumann PJ. Unintended benefits: the potential economic impact of addressing risk factors to prevent Alzheimer's disease. Health Affairs (Millwood). 2014 Apr;33(4):547-54. Journal: Health Affairs Read Publication

FDA’s proposed ban on trans fats: how do the costs and benefits stack up?

Published on March 1, 2014 Citation: Cohen, JT. FDA’s proposed ban on trans fats: how do the costs and benefits stack up? Clinical Therapeutics. 2014 Jan; 36(3): 322-327. Journal: Clinical Therapeutics Read Publication

Is the US "leading from behind" on health policy?

Published on March 1, 2014 Citation: Neumann PJ, Saret CJ. Is the US "leading from behind" on health policy? European Journal of Health Economics. 2014 Mar;15(2):113-6. Journal: European Journal of Health Economics Read Publication

Does framing of cancer survival affect perceived value of care? A willingness-to-pay survey of US residents

Published on January 9, 2014 Citation: Lin PJ, Concannon TW, Greenberg D, Cohen JT, Rossi G, Hille J, Auerbach HR, Fang CH, Nadler ES, Neumann PJ. Does framing of cancer survival affect perceived value of care? A willingness-to-pay survey of U.S. residents. Expert Review of Pharmacoeconomics and Outcomes Research. 2013 Aug. Journal: Expert Review of Pharmacoeconomics & Outcomes Research Read Publication

A survey of individuals in US-based pharmaceutical industry HEOR departments: attitudes on policy topics

Published on January 9, 2014 Citation: Neumann PJ, Saret CJ. A survey of individuals in US-based pharmaceutical industry HEOR departments: attitudes on policy topics. Expert Rev Pharmacoecon Outcomes Res. 2013 Oct;13(5):657-61. Journal: Expert Review of Pharmacoeconomics & Outcomes Research Read Publication

The economic value of personalized medicine tests: what we know and what we need to know

Published on October 17, 2013 Citation: Phillips KA, Ann Sakowski J, Trosman J, Douglas MP, Liang SY, Neumann P. The economic value of personalized medicine tests: what we know and what we need to know. Genet Med. 2013 Nov 14. Journal: Genetics in Medicine Read Publication

Which is more valuable, longer survival or better quality of life?

Published on July 11, 2013 Citation: Greenberg D, Hammerman A, Vinker S, Shani A, Yermiahu Y, Neumann PJ. Which is more valuable, longer survival or better quality of life? Value in Health. 2013 Jul-Aug;16(5):842-7. Journal: Value in Health Read Publication

Where are we on "risk-sharing" agreements?

Published on June 17, 2013 Citation: Neumann PJ. Where are we on "risk-sharing" agreements? Value in Health. 2013 Aug;16(5):701-2. Journal: Value in Health Read Publication